ifosfamide has been researched along with Hepatocellular Carcinoma in 6 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "A phase II study of high-dose ifosfamide in hepatocellular carcinoma was conducted among 17 Chinese patients." | 9.07 | Phase II study of high-dose ifosfamide in hepatocellular carcinoma. ( Lau, WY; Leung, N; Leung, WT; Li, AK; Lin, J; Shiu, W; Tao, M, 1993) |
| "A phase II study of high-dose ifosfamide in hepatocellular carcinoma was conducted among 17 Chinese patients." | 5.07 | Phase II study of high-dose ifosfamide in hepatocellular carcinoma. ( Lau, WY; Leung, N; Leung, WT; Li, AK; Lin, J; Shiu, W; Tao, M, 1993) |
| "The Barcelona Clinic Liver Cancer (BCLC) staging system is commonly used to classify hepatocellular carcinoma (HCC) patients." | 1.56 | Validation of prognostic accuracy of MESH, HKLC, and BCLC classifications in a large German cohort of hepatocellular carcinoma patients. ( Czauderna, C; Galle, PR; Heil, E; Heinrich, B; Heinrich, S; Kloeckner, R; Koch, S; Marquardt, JU; Philippe P Diggs, L; Schmidtmann, I; Sprinzl, M; Weinmann, A; Wörns, MA, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 3 (50.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Heinrich, S | 1 |
| Sprinzl, M | 1 |
| Schmidtmann, I | 1 |
| Heil, E | 1 |
| Koch, S | 1 |
| Czauderna, C | 1 |
| Heinrich, B | 1 |
| Philippe P Diggs, L | 1 |
| Wörns, MA | 1 |
| Kloeckner, R | 1 |
| Galle, PR | 1 |
| Marquardt, JU | 1 |
| Weinmann, A | 1 |
| Zhu-Ge, J | 1 |
| Yu, YN | 1 |
| Lin, J | 1 |
| Shiu, W | 1 |
| Leung, WT | 1 |
| Tao, M | 1 |
| Leung, N | 1 |
| Lau, WY | 1 |
| Li, AK | 1 |
| Malik, IA | 1 |
| Khan, WA | 1 |
| Haq, S | 1 |
| Sabih, M | 1 |
| Staines, A | 1 |
| Cullen, S | 1 |
| Guiney, EJ | 1 |
| Fitzgerald, RJ | 1 |
| Breatnach, F | 1 |
| Thongprasert, S | 1 |
| Klunklin, K | 1 |
| Phornphutkul, K | 1 |
| Prisontarangkul, OA | 1 |
| Chaimongkol, B | 1 |
| Sivasomboon, B | 1 |
2 trials available for ifosfamide and Hepatocellular Carcinoma
| Article | Year |
|---|---|
Phase II study of high-dose ifosfamide in hepatocellular carcinoma.
Topics: Adult; Aged; Alopecia; Carcinoma, Hepatocellular; Clinical Trials, Phase II as Topic; Female; Humans | 1993 |
A prospective phase II trial to evaluate the efficacy and toxicity of hepatic arterial infusion of ifosfamide in patients with inoperable localized hepatocellular carcinoma.
Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Carcinoma, Hepatocellular; Humans; Ifosfamide; Infus | 1997 |
4 other studies available for ifosfamide and Hepatocellular Carcinoma
| Article | Year |
|---|---|
Validation of prognostic accuracy of MESH, HKLC, and BCLC classifications in a large German cohort of hepatocellular carcinoma patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic C | 2020 |
Enzyme activity analysis of CYP2C18 with exon 5 skipped.
Topics: Alternative Splicing; Aryl Hydrocarbon Hydroxylases; Carcinoma, Hepatocellular; Cell Line, Tumor; Ce | 2004 |
Combination chemotherapy in the treatment of hepatoblastoma.
Topics: Adenomatous Polyposis Coli; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Biom | 1990 |
Phase II study of ifosfamide (Holoxan) in hepatoma.
Topics: Adult; Carcinoma, Hepatocellular; Drug Evaluation; Female; Humans; Ifosfamide; Leukocyte Count; Live | 1988 |